ES2659353T3 - Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer - Google Patents
Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer Download PDFInfo
- Publication number
- ES2659353T3 ES2659353T3 ES10825771.8T ES10825771T ES2659353T3 ES 2659353 T3 ES2659353 T3 ES 2659353T3 ES 10825771 T ES10825771 T ES 10825771T ES 2659353 T3 ES2659353 T3 ES 2659353T3
- Authority
- ES
- Spain
- Prior art keywords
- food
- component
- meals
- providing
- cancer patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/65—Sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Human Resources & Organizations (AREA)
- Marketing (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un envase de comida terapéutica para su uso para proporcionar comidas a un paciente con cáncer, que retrasa el crecimiento del cáncer y mejora la eficacia de los fármacos quimioterapéuticos, comprendiendo el envase de comida terapéutica: un primer componente de comida dividido en comidas, que proporciona al paciente con cáncer como máximo el 50% de la ingesta calórica normal del paciente, proporcionando el primer componente de comida, al paciente con cáncer, de 700 a 1200 kcal/día, procediendo de la grasa al menos el 50% de las kilocalorías, proporcionando el primer componente de comida, comidas durante un primer período de tiempo predeterminado de aproximadamente 1 a 5 días; un segundo componente de comida dividido en comidas, proporcionando el primer componente de comida al paciente con cáncer, como máximo 500 kcal/día, proporcionando el segundo componente de comida, comidas durante un segundo período de tiempo predeterminado de aproximadamente 2 a 7 días; y una composición reponedora que comprende aminoácidos esenciales y otros aminoácidos no esenciales, ácidos grasos esenciales, minerales, vitaminas y/o extractos de verduras, durante un tercer período de tiempo predeterminado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25415409P | 2009-10-22 | 2009-10-22 | |
US254154P | 2009-10-22 | ||
PCT/US2010/053821 WO2011050302A2 (en) | 2009-10-22 | 2010-10-22 | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2659353T3 true ES2659353T3 (es) | 2018-03-14 |
Family
ID=43900993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10825771.8T Active ES2659353T3 (es) | 2009-10-22 | 2010-10-22 | Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer |
Country Status (13)
Country | Link |
---|---|
US (2) | US20110118528A1 (es) |
EP (1) | EP2490684B1 (es) |
JP (1) | JP2013508411A (es) |
CN (1) | CN102753162A (es) |
AU (2) | AU2010310515B2 (es) |
BR (1) | BR112012009423A2 (es) |
CA (1) | CA2779282C (es) |
DK (1) | DK2490684T3 (es) |
ES (1) | ES2659353T3 (es) |
PL (1) | PL2490684T3 (es) |
PT (1) | PT2490684T (es) |
RU (1) | RU2549954C2 (es) |
WO (1) | WO2011050302A2 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2822178T3 (es) * | 2012-10-22 | 2021-04-29 | Univ Southern California | Formulaciones dietéticas que promueven la regeneración de tejidos/órganos |
US9237761B2 (en) * | 2013-02-12 | 2016-01-19 | University Of Southern California | Methods and diets for lowering glucose and/or IGF-1 levels |
US9386790B2 (en) * | 2013-07-01 | 2016-07-12 | University Of Southern California | Fasting condition as dietary treatment of diabetes |
US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
ES2846153T3 (es) * | 2014-03-06 | 2021-07-28 | Univ Southern California | Uso de régimen de inanición a corto plazo en combinación con inhibidores de cinasa para potenciar la eficacia y viabilidad de fármacos quimioterápicos tradicionales y revertir efectos secundarios de cinasas en células y tejidos normales |
JP2017509671A (ja) * | 2014-03-28 | 2017-04-06 | ウニベルシタ デリィ ストゥディ ディ ジェノバ | カロリー摂取量減少と協同したがん治療方法で使用されるチロシンキナーゼ阻害剤 |
EP3125904A4 (en) * | 2014-04-02 | 2017-08-30 | University of Southern California | Autoimmunity and multiple sclerosis treatment |
CA2982875C (en) | 2015-04-16 | 2021-10-19 | University Of Southern California | Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone |
CA2984891A1 (en) | 2015-05-06 | 2016-11-10 | University Of Southern California | Fasting mimicking and enhancing diet for treating hypertension and lipid disorders |
WO2017050849A1 (en) * | 2015-09-21 | 2017-03-30 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | New therapeutic strategies against blood cancer |
US20190029301A1 (en) * | 2016-01-12 | 2019-01-31 | University Of Southern California | Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers |
US10660932B2 (en) | 2016-02-15 | 2020-05-26 | University Of Southern California | Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases |
EP4218751A3 (en) * | 2016-02-23 | 2024-03-06 | Cancer Research Technology Ltd | Dietary product devoid of at least two non essential amino acid |
ES2871060T3 (es) | 2016-05-11 | 2021-10-28 | Univ Southern California | Dieta que imita el ayuno (FMD) como tratamiento inmunorregulador para enfermedades digestivas autoinmunitarias/inflamatorias |
IT201700008499A1 (it) * | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
CN107951892A (zh) * | 2018-01-19 | 2018-04-24 | 丽水学院 | 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用 |
AU2019236242A1 (en) | 2018-03-15 | 2020-10-01 | University Of Southern California | Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology |
DE212018000421U1 (de) * | 2018-07-18 | 2021-03-01 | Andreas Michalsen | Auswirkungen einer kurzzeitigen Diät, die Fasten imitiert, auf die Lebensqualität und die Verträglichkeit einer Chemotherapie bei Patientinnen mit Krebs |
CA3119100C (en) | 2018-11-09 | 2024-06-04 | Valter D. Longo | Nutrition bar for intermittent fasting-mimicking |
JP6747702B1 (ja) * | 2019-05-10 | 2020-08-26 | 株式会社医療情報技術研究所 | 栄養処方管理システム |
EP3968785A4 (en) | 2019-05-14 | 2023-01-11 | Tyme, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER |
JP7376718B2 (ja) * | 2019-12-13 | 2023-11-08 | 株式会社ベリタスバイオセラピューティクス | 癌の予防または治療用薬学組成物 |
IT202000007153A1 (it) | 2020-04-03 | 2021-10-03 | Ifom Fondazione St Firc Di Oncologia Molecolare | Apporto calorico ridotto e immunoterapia per il trattamento del cancro |
US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
CA3205396A1 (en) * | 2020-12-17 | 2022-06-23 | Licia Rivoltini | Diet preparation for the nutrition of cancer patients with a restricted calorie intake |
EP4066823A1 (en) | 2021-03-30 | 2022-10-05 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Reduced caloric intake and anticancer agents for the treatment of cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2074731C1 (ru) * | 1994-12-29 | 1997-03-10 | Игорь Александрович Бойко | Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных |
JP4740426B2 (ja) * | 1997-03-17 | 2011-08-03 | ビーティージー・インターナショナル・リミテッド | 治療用組成物 |
WO2001006983A2 (en) * | 1999-07-22 | 2001-02-01 | Incell Corporation, Llc | Fatty acids to minimize cancer therapy side effects |
WO2005117542A2 (en) * | 2004-05-10 | 2005-12-15 | Novacea, Inc. | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
WO2006043966A2 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
US20070116802A1 (en) * | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
US20080038367A1 (en) * | 2006-08-11 | 2008-02-14 | Sal Saloum | Nutritional supplement compositions and methods of preparing |
RU2354369C2 (ru) * | 2007-03-16 | 2009-05-10 | Михаил Владимирович Кутушов | Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов |
US8211700B2 (en) * | 2007-03-28 | 2012-07-03 | University Of Southern California | Induction of differential stress resistance and uses thereof |
WO2009070378A1 (en) * | 2007-11-26 | 2009-06-04 | Nestec S.A. | Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
-
2010
- 2010-10-22 ES ES10825771.8T patent/ES2659353T3/es active Active
- 2010-10-22 CA CA2779282A patent/CA2779282C/en active Active
- 2010-10-22 DK DK10825771.8T patent/DK2490684T3/en active
- 2010-10-22 JP JP2012535426A patent/JP2013508411A/ja active Pending
- 2010-10-22 RU RU2012118588/15A patent/RU2549954C2/ru active
- 2010-10-22 EP EP10825771.8A patent/EP2490684B1/en active Active
- 2010-10-22 AU AU2010310515A patent/AU2010310515B2/en active Active
- 2010-10-22 PL PL10825771T patent/PL2490684T3/pl unknown
- 2010-10-22 BR BR112012009423A patent/BR112012009423A2/pt not_active Application Discontinuation
- 2010-10-22 WO PCT/US2010/053821 patent/WO2011050302A2/en active Application Filing
- 2010-10-22 PT PT108257718T patent/PT2490684T/pt unknown
- 2010-10-22 US US12/910,508 patent/US20110118528A1/en not_active Abandoned
- 2010-10-22 CN CN2010800560747A patent/CN102753162A/zh active Pending
-
2016
- 2016-03-11 AU AU2016201607A patent/AU2016201607B2/en active Active
-
2021
- 2021-03-17 US US17/204,419 patent/US20210209516A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112012009423A2 (pt) | 2017-06-13 |
EP2490684A2 (en) | 2012-08-29 |
US20110118528A1 (en) | 2011-05-19 |
DK2490684T3 (en) | 2018-04-09 |
WO2011050302A3 (en) | 2011-08-25 |
PT2490684T (pt) | 2018-04-02 |
CN102753162A (zh) | 2012-10-24 |
AU2016201607B2 (en) | 2017-11-30 |
WO2011050302A2 (en) | 2011-04-28 |
AU2010310515B2 (en) | 2016-01-07 |
CA2779282A1 (en) | 2011-04-28 |
US20210209516A1 (en) | 2021-07-08 |
EP2490684B1 (en) | 2018-01-03 |
AU2010310515A1 (en) | 2012-05-17 |
CA2779282C (en) | 2017-12-05 |
PL2490684T3 (pl) | 2018-07-31 |
AU2016201607A1 (en) | 2016-03-31 |
RU2012118588A (ru) | 2013-11-27 |
JP2013508411A (ja) | 2013-03-07 |
RU2549954C2 (ru) | 2015-05-10 |
EP2490684A4 (en) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2659353T3 (es) | Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer | |
Farahat et al. | Effect of dietary supplementation of grape seed extract on the growth performance, lipid profile, antioxidant status and immune response of broiler chickens | |
ES2807781T3 (es) | Composición de dieta para usar en un método terapéutico para reducir los niveles de glucosa en sangre y/o de IGF-1 | |
ES2954473T3 (es) | Aditivo para alimentación de ganado | |
ES2571856T3 (es) | Uso de composiciones nutricionales para prevenir la adiposidad visceral | |
CO6351747A2 (es) | Composicion nutricional para promover desarrollo y crecimiento saludables | |
RU2006130739A (ru) | Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний | |
BR112012033422A2 (pt) | composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas | |
BR112017009678A2 (pt) | composição optimizada de nutrientes de ácidos graxos e método de preparação da mesma | |
EA201270274A1 (ru) | Натуральный экстракт из цельных плодов банана (musa spp.) | |
Kale et al. | Role of antioxidants and nutrition in oxidative stress: A review | |
JP2015510888A5 (es) | ||
MX2009001156A (es) | Composiciones de vitamina d y metodo de administracion a un ser humano. | |
ES2947500T3 (es) | Composiciones orales antiparasitarias | |
Lim et al. | Nutrients and dietary supplements for osteoarthritis | |
Owens | Nutritional support to counteract muscle atrophy | |
HK1118722A1 (en) | Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases | |
Alagbe et al. | Albizia lebbeck stem bark aqueous extract as alternative to antibiotic feed additives in broiler chicks diets: Haematology, Serum indices and oxidative status | |
Sahin et al. | Role of the antioxidant defence system and transcription factors in preventing heat stress in poultry: a dietary approach | |
ES2716278T3 (es) | Productos para administración oral que comprenden extractos de granada Punica granatum, pensados para un animal de compañía, y aplicaciones de los mismos | |
Sutili et al. | Clove Oil, eugenol effective anesthetics for silver catfish, other Brazilian species | |
EA202092105A1 (ru) | Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбумина | |
US10499664B2 (en) | Fish feed formulation of Hypericum perforatum, Rosamarinus officianalis or a mixture thereof | |
Alalwan | Nutraceuticals and their role in promoting musculoskeletal healthy aging. | |
WO2019040459A3 (en) | Composition and nutritional supplement made therefrom |